The Society for Post-Acute and Long-Term Care Medicine (AMDA) this week launched a new initiative to cut down on over-prescribing in post-acute and long-term care settings.
The program, called Drive to Deprescribe: Optimizing Medication Use in PALTC, aims to reduce medication use by 25% and optimize medication for long-stay patients, the society said.
AMDA said polypharmacy has long been an industry concern, noting that some nursing home residents take as many as 15 drugs. The society plans to measure the initiative's success using key metrics and will share results throughout the program.
As of Wednesday, 1,300 facilities had enrolled in the program.
"We are excited to introduce this important initiative to prescribers, pharmacists, CNOs, CMOs and others working in the long-term care setting and are thrilled with the initial positive response from facilities," AMDA Executive Director Christopher Laxton said in a statement. "There is clear recognition of the many adverse impacts of polypharmacy in our setting."
The initiative's kickoff meeting was May 20 and will be followed by a mixture of webinars and virtual office hours monthly for members. It's being run by AMDA and the American Society of Consultant Pharmacists.